BACKGROUND OF THE INVENTION
1. Field of the Invention
[0001] The present invention relates to a chewable confectionery composition which reduces
the presence of dental plaque from the chewing surfaces of teeth and more particularly
the invention relates to a chewable confectionery composition which contains a small
but effective amount of a an enzyme effective to disrupt or interfere with plaque
formation and adhesion to tooth surfaces.
2. The Prior Art
[0002] Oral compositions such as toothpastes, gels and mouth washes are designed to loosen
and remove plaque in conjunction with a regular toothbrushing regimen. Dental plaque
is present to some degree, in the form of a film, on virtually all dental surfaces.
It is a byproduct of microbial growth, and comprises a dense microbial layer consisting
of a mass of microorganisms embedded in a polysaccharide matrix. Plaque itself adheres
firmly to dental surfaces and is removed only with difficulty even through a rigorous
brushing regimen. Moreover, plaque rapidly reforms on the tooth surface after it is
removed. Plaque may form on any part of the tooth surface, and is found particularly
at the gingival margin, in cracks in the enamel , and on the surface of dental calculus.
The problem associated with the formation of plaque on the teeth lies in the tendency
of plaque to build up and eventually produce gingivitis, periodontitis and other types
of periodontal disease, as well as dental caries and dental calculus.
[0003] Plaque formation is an ongoing process. Although various oral care products are available
to control plaque formation such as toothpastes and mouth rinse, the disadvantage
of these products is that only a relatively short time during which the teeth are
being brushed or the mouth is being rinsed is available for these preparations to
take effect. A further disadvantage of these toothpaste and mouth rinse products is
the general infrequency of use, that is, most dental hygiene products are used once
or perhaps twice daily and seldom when they are most needed, e.g., after meals and
snacks. Thus food deposits which build up as a result of eating throughout the day
are left in the oral cavity for long periods of time thereby promoting microbial growth
and formation of plaque on tooth surfaces.
[0004] It is known to the art to incorporate antimicrobial agents in oral compositions wherein
these agents destroy or inhibit oral bacteria responsible for plaque formation. Other
agents are also incorporated in the oral composition to reduce plaque formation on
teeth. For example, it is known to incorporate enzymes such as proteases and carbohydrases
in oral compositions, which enzymes disrupt or interfere with plaque formation and
bacterial adhesion to tooth surfaces.
[0005] Chewable tablets and gums have been used as vehicles for introducing various chemical
agents to tooth surfaces including enzymes such as amylase enzymes (
US 4,740,368) oxidoreductases such as glucose oxidase and lactoperoxidase enzymes (
US 4,564,519).
[0006] ES-A-2 131 006 discloses a chewing gum or a tablet comprising 0.2-5% papain and a non-cariogenic
sweetener, the papain enzyme functioning to disrupt or interfere with dental plaque
and tartar formation.
[0007] GB-A-1 294 767 teaches a chewing gum or chewable tablet comprising an enzyme for the prevention
and treatment of dental plaque.
[0008] In
US-A-4,178,362, the use of glucose oxidase enzyme is taught as an effective agent that forms hydrogen
peroxide, which loosens and removes plaque from teeth.
[0009] JP-A-04 173 056 describes a chewing gum which comprises aspartame and a dextranase or mutanase as
anticariogenic component.
[0010] US-A-2002/0 006 385 is directed to the use of starch-hydrolysing or starch-modifying enzymes in oral
care compositions.
[0011] US-A-3,235,460 describes an enzymatically active chewing gum composition comprising pancreatin which
catalyses the hydrolysis of the organic matrix, the probable foundation of calculus.
[0012] In
JP-A-63 104908, a chewable composition is taught which comprises glycoamylase, a non-cariogenic
sweetener and an antioxidant.
[0013] US-A-5,747,005 teaches an oil-based dentifrice which contains an enzyme selected from the group
of proteases, lipases and saccharinoses, together with a high amount of Vitamin E.
[0014] In
US-A-5,320,830, all kinds of oral compositions are taught which may comprise enzymes and have a
pH in the range of 4.0-6.0.
[0015] A critical requirement, however, for these compositions is that they are stable and
have a long shelf-life, which requirement has limited the use of these compositions
because normally, the active agents incorporated in these compositions that provide
oral care benefits such as plaque reduction are not stable under ambient conditions
of humidity and temperature and as a result the agents quickly become degraded to
concentrations of limited efficacy and particularly, enzymes which denature during
the manufacturing process.
[0016] In view of the inconvenience of using toothpaste and mouth rinse products when away
from home, the art is seeking portable products in the form of chewable confections
such as tablets and gums which can be used throughout the day, particularly after
eating, and which provide antiplaque benefits comparable to those obtained by regular
brushing with a toothpaste or use of a mouthrinse.
SUMMARY OF THE INVENTION
[0017] In accordance with the present invention, there is provided a chewable confectionery
composition such as a chewable tablet or gum comprised of a small but effective amount
of a plaque reducing enzyme, a non-cariogenic sweetener and optionally a plasticizing/softening
agent.
[0018] Particularly, the invention relates to a chewable confectionery composition delivering
to tooth surfaces a unit dose of a plaque reducing enzyme the composition comprising
(A) 0.1 to 3 wt.% of an enzyme which functions to disrupt or interfere with plaque
formation and adhesion to tooth surfaces, which enzyme is a protease, (B) a solid
base material, and (C) the composition further comprising (D) an enzyme stabilising
agent that is an agent that by chelating metal impurities protects the enzyme from
inactivation or from 0.05 to 1.5 wt.% of a reducing agent stabilizing the enzyme against
oxidation; (E) less than 5 wt.% water, wherein the protease is extracted from a natural
fruit product and is incorporated into the solid base material of the composition
at a temperature of less than 80°C.
[0019] Due to the inherent nature of the chewable tablet or gum product, prolonged contact
with the tooth surfaces is achieved when the product is chewed, forming a paste with
saliva containing the enzyme which coats the tooth surfaces. The delivery of the enzyme
in a chewable tablet or gum form insures that an adequate dosage of the antiplaque
enzyme is deliverable when the product is chewed by the user. The chewable confectionery
composition of the present invention is portable and can be packaged and stored in
a consumers pocket or purse for consumption anytime and anywhere.
[0020] When the chewable confectionery composition of the present invention is placed within
the mouth and chewed, an effective antiplaque amount of the enzyme is released from
the composition into the saliva where it can reach the surface of the teeth to prevent
further plaque accumulation. The tablet or gum of the present invention is formed
so as to release the enzyme over a period of 0.5 to 2 minutes. Consistent daily use
of the chewable tablets or gums of the present invention will then obtain maximum
plaque reduction from the teeth of the consumer.
[0021] The term "chewable confectionery composition" as used herein includes within its
meaning chewing gum, and chewable and orally soluble tablets, troches and lozenges.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0022] The composition of the present invention as stated is a chewable product which reduces
plaque and contains as the active ingredient, a protease enzyme. The product is preferably
sugarless.
[0023] A representative chewable antiplaque tablet in accordance with the practice of this
invention contains about 0.1 to 3% by weight of an enzyme, 0.5 to 5% by weight of
a combination plasticizing/softening ingredient and about 50 to about 90% by weight
of a non-cariogenic sweetener. In addition to the ingredients discussed above for
tablets, chewable gum compositions will contain 10 to 40% by weight of a gum base.
[0024] As water promotes the denaturization of the papain enzyme, the presence of water
in the chewable confectionery product of the present invention should be at relatively
low concentrations in order to impart maximum stability and shelf life to the chewable.
For this purpose, it has been found essential to limit the total amount of water present
in the chewable product to no more than 5% by weight.
Enzymes
[0025] The enzymes useful in the practice of the present invention include carbohydrases
such as glucoamylase and enzymes extracted from natural fruit products such as proteases
which breakdown or hydrolyze proteins.
[0026] Protease enzymes useful in the practice of the present invention include those extracted
from natural fruit products. The proteolytic enzymes are obtained from natural sources
or by the action of microorganisms having a nitrogen source and a carbon source. Examples
of proteolylic enzymes useful in the practice of the present invention include the
naturally occurring enzymes papain (from papaya), bromelain (from pineapple), as well
as serine proteases such as chymotrypsin. Additional enzymes include ficin and alcalase.
Papain is a protease enzyme preferred for use in the practice of the present invention,
the papain having an activity of 150 to 939 MCU per milligram as determined by the
Milk Clot Assay Test of the Biddle Sawyer Group (see
J. Biol. Chem., vol. 121, pages 737-745). The protease enzymes are included in the compositions of the present invention
at a concentration of 0.1 to 3% by weight and preferably 0.2 to 2% by weight
[0027] Enzymes which may beneficially be used in combination with the proteolytic enzymes
and glucoamylase enzymes include carbohydrases such as glucoamylase, alpha-amylase,
beta-amylase, , tannase and lipases such as plant lipase, gastric lipase and pancreatic
lipase.
[0028] Glucoamylase is a saccharifying glucoamylase of
Aspergillus niger origin cultivated by fermentation. This enzyme can hydrolyze both the alpha-D-1,6
glucosidic branch points and the alpha-1,4 glucosidic bonds of glucosyl oligosaccharides.
Additional carbohydrases useful in accordance with this invention are alpha and beta-amylase,
dextranase and mutanase. Glucoamylase is a preferred enzyme and is incorporated in
the oral composition of the present invention at a concentration of 0.001 to 2% by
weight and preferably 0.01 to 0.55% by weight.
[0029] The lipase enzyme is derived from a select strain of
Aspergillus niger, exhibiting random cleaving of the 1,3 positions of fats and oils. The enzyme has
maximum lipolytic activity at pH 5.0 to 7.0 when assayed with olive oil. The enzyme
has a measured activity of 120,000 lipase units per gram. The lipase may be included
in the dentifrice composition at a concentration of 0.010 to 5.0% by weight and preferably
0.02 to 0.10 % by weight.
[0030] The presence of tannase enzyme can be further beneficial in facilitating the breakdown
of extrinsic stain. Tannase enzymes have been purified from
Aspergillus niger and
Aspergillus allianceus and are useful in the hydrolysis of tannins, known to discolor the tooth surface.
[0031] Other suitable enzymes which can comprise the present invention include lysozyme,
derived from egg white, which contains a single polypeptide chain crosslinked by four
disulfide bonds having a molecular weight of 14,600 daltons. The enzyme can exhibit
antibacterial properties by facilitating the hydrolysis of bacterial cell walls cleaving
the glycosidic bond between carbon number 1 of N-acetylmuramic acid and carbon number
4 of N-acetyl-D-glucosamine, which in vivo, these two corbohydrates are polymerized
to form the cell wall polysaccharide. Additionally, pectinase, an enzyme that is present
in most plants facilitates the hydrolysis of the polysaccharide pectin into sugars
and galacturonic acid. Finally, glucanase, which may be utilized to catalyze the breakdown
of complex carbohydrates to glucans and the hydrolysis of beta glucan to glucose.
Enzyme Stabilizing Agents
[0032] Enzyme stabilizing agents which protect the enzyme from inactivation by chelating
metal impurities present in the chewable confectionery composition of the present
invention are incorporated in the composition and may include ethylene diamine tetraacetic
acid (EDTA) and sodium gluconate at concentrations between 0.01 and 1% by weight,
preferably between 0.1 and 0.5% by weight. Agents stabilizing the enzyme against oxidation
include reducing agents such as sodium bisulfite, metal gallates, potassium stannate,
sodium stannate, ammonium sulfate, 3,5,-di-tert-butyl-4-hydroxytoluene (BHT), Vitamin
E (α, β,y, forms) /Vitamin E acetate and ascorbic acid. Potassium stannate is an enzyme
stabilizing agent preferred for use in the practice of the present invention. The
reducing agent is present in the oral composition of the present invention at a concentration
between 0.05 to 1.5% by weight, preferably between 0.1 and 0.75% by weight.
TABLETS
Plasticizing/Softening Agents
[0033] Plasticizing/softening agents suitable for use in the preparation of tablets in accordance
with the practice of this invention, include propylene glycol, glycerol, acetylated
monoglyceride, glyceryl triacetate, glyceryl diacetate, lecithin, glycerin, and mixtures
thereof. In a preferred embodiment of this invention, a combination of lecithin and
glycerin is used, generally in amounts of 0.5% to 3.0% by weight, 0.1% to 1.0% lecithin
and 1.0% to 1.0% by weight glycerin by weight, based on the weight of the total chewable
tablet composition.
Sweeteners
[0034] The sweetening agent ingredient used in the practice of the present invention include
bulk sweeteners such as the polyols of 5 to 12 carbon atoms substituted with 5 to
9 hydroxyl groups such as sugar alcohols including xylitol, sorbitol, mannitol. Sugar
alcohols provide bulk or texture to the chewable compositions of the present invention
and are utilized in amounts of 25% to 90% by weight preferably 40% to 85% by weight
[0035] Artificial sweeteners include as sodium or calcium saccharin salts, cyclamate salts,
such as the sodium salt and the like, and the free acid form of saccharin; dipeptide
based sweetening agents such as L-aspartyl-L-phenyl-alanine methyl ester, dihydrochalcone;
glycyrrhizin; and the synthetic sweetener 3,6-dihydro-6-methyl-1, 1,2,3-oxathiazin-4-one-2,2-dioxide,
particularly the potassium (Acesulfame-K), sodium and calcium salts. Artificial sweeteners
are present in the chewable confectionery compositions of the present invention at
a concentration of 0.1 to 1% by weight.
[0036] Preferred bulk sweeteners include Lycasin, a commercially available mixture of sorbitol,
malitol and high molecular weight dextrans disclosed in Re 26,969 and Isomalt, a sugar
alcohol of a disaccharide such as alpha-D-glucopyranosyl-1, 6-mannitol, its isomer,
alpha, D-glucopyranosyl-1, 6-sorbitol or a mixture thereof which is obtained by the
hydrogenation of palatinose which is converted from sucrose as a raw material with
glycosyltransferase. A preferred artificial sweetener is aspartame.
[0037] In a preferred embodiment of this invention, the sweetening agent used is a combination
of an artificial sweetener such as aspartame and acesulfame and the bulk sweeteners
such as Lycasin and Isomalt, the artificial sweetener being present generally in amounts
to 0.05% to 0.3% by weight and preferably 0.18% to 0.22% by weight and 40% to 60%
by weight, preferably (45% to 55% by weight Lycasin and 15% to 35% by weight preferably
20% to 30% by weight Isomalt.
Flavoring Agents
[0038] One or more flavoring agents in liquid powder or encapsulated form are used in the
chewable composition of this invention. A variety of flavors known in the art may
be used, including essential oils, such as cinnamon, spearmint, peppermint, menthol,
birch, anise wintergreen oil and eucalyptus oil. Natural fruit flavors are preferably
derived from the essence of fruits, such as apple, pear, peach, strawberry, cherry,
apricot, orange, watermelon, banana; bean derived flavors such as coffee, and cocoa;
wine derived curacao zin, and pungent materials, such as affinin, Pepper, and mustard.
Flavoring agents are incorporated in the chewable confectionery compositions at a
concentration of 0.5 to 5% by weight and preferably 1.0 to 3.0% by weight
Other Ingredients
[0039] Calcium salts may be incorporated in the chewable compositions of the resent invention
as fillers and anticavity agents. Examples of the calcium salts to be used in the
present invention as the anticaries agent are, for example, calcium chloride, calcium
nitrate, calcium sulfate, dicalcium phosphate dihydrate, calcium carbonate, calcium
citrate, calcium, hydrogen pyrophosphate, calcium gluconate, calcium glycerophosphate,
calcium hydroxide, calcium oxide and calcium silicate. The calcium salt is present
in the tablet or gum at a concentration of 5 to 20% by weight and preferably 7 to
10% by weight. Alkine agents such as sodium bicarbonate maybe incorporated in the
chewable confectionery composition of the present invention to provide additional
cleaning and breath freshening properties to the composition.
Chewing Gum
[0040] The chewing gum of the present invention is preferably a sugarless chewing gum containing
the enzyme as sugarless gums do not promote tooth decay. Chewing gum formulations
in which the enzymes of the present invention may be incorporated are well known in
the art and typically contain, in addition to, a chewing gum base, one or more plasticizing
agents; at least one sweetening agent and at least one flavoring agent.
[0041] Gum base materials suitable for use in the practice of this invention are well known
in the art and include natural or synthetic gum bases or mixtures thereof. Representative
natural gums or elastomers include chicle, natural rubber, jelutong, balata, guttapercha,
lechi caspi, sorva, guttakay, crown gum, perillo, or mixtures thereof Representative
synthetic gums or elastomers include butadiene-styrene copolymers, polyisobutylene
and isobutylene-isoprene copolymers.
[0042] The gum base is incorporated in the chewing gum product at a concentration of 10
to 40% by weight and preferably 20 to 5% by weight.
[0043] Plasticizing/softening agents commonly used in chewing gum compositions are suitable
for use in this invention, including gelatin, waxes and mixtures thereof in amounts
of 0.1 to 5% by weight.
[0044] The sweetening agent ingredient used in the practice of this invention may be selected
from a wide range of materials. Bulk sweeteners include the same sweeteners used for
the preparation of chewable tablets as are artificial sweeteners. The bulk sweetener
is present in the chewing gum composition of the present invention in amounts of 40
to 80 % by weight and preferably 50 to 75 % by weight. The artificial sweetener is
present in the chewing gum composition of the present invention in amounts of 0.1
to 2% by weight and preferably 0.3 to 1% by weight.
[0045] In addition to the ingredients listed above, the gum compositions may also include
conventional additives such as colorants, and flavoring agents. For example, titanium
dioxide may be utilized as a colorant. A variety of flavors known in the art may be
used, including essential oils, such as cinnamon, spearmint, peppermint, menthol,
birch, and anise ; natural fruit flavors derived from the essence of fruits, such
as apple, pear, peach, strawberry, cheery, apricot, orange, watermelon, and banana;
bean-derived flavors, such as coffee and cocoa. Flavoring agents are incorporated
in the chewing gum formulation at a concentration of 0.5 to 5 % by weight and preferably
1 to 3 % by weight.
Method of Manufacture
[0046] The challenge in incorporating enzymes into the confectionary composition is maintaining
enzymatic stability and activity during storage. Enzymes are quaternary proteins whose
structure, function, and stability are sensitive to chemical environment and processing
parameters. Enzymes denature in harsh chemical environment and at high temperatures.
Formulation and processing procedures are optimized at low moisture and low temperature
for both the enzyme chewable tablet and the enzyme gum to preserve enzymatic activity
and in vivo efficacy.
[0047] The chewable composition of the present invention is made by any suitable process
where the protease enzyme is incorporated into the solid base material such that no
water or a limited amount of ingredients that absorb water are used that would result
in undesirable amounts of water being introduced into the composition during processing
or storage. Further, at the time the enzyme is introduced into ingredients used to
prepare the chewable composition that the temperature at the time of addition is less
then about 80°C. Therefore, it is critical to the practice of the present invention
that the composition contain less than 5% by weight water and preferably less than
3% by weight water and that the temperature at which processing of the enzyme occurs
be less than about 80°C. The presence in the composition of water in amounts greater
than 5% by weight or the use of temperatures in excess of 80°C will act to denature
the protease enzyme thereby substantially reducing the Efficacy of the enzyme in effecting
plaque reduction on teeth.
[0048] One method for manufacturing the composition of the invention comprises first heating
the base material to a temperature sufficient to drive off any water in the composition.
The base material is then cooled to a temperature at which the enzyme and other temperature
sensitive ingredients such as plasticizers, other sweeteners are incorporated and
mixed into the base material.
[0049] Formulations, equipment and processing techniques have been well developed in the
art for preparing and packaging chewing gum and chewable tablets and lozenges. As
the enzyme is subject to deterioration and inactivation under conditions such as high
shear and elevated temperatures, processing conditions are controlled during the time
period that the enzymes are admixed with the-other ingredients-of the formulation
and converted into finished products so that the temperature at the time of admixture
does not exceed about 80°C for any extended period of time.
[0050] The tablets of the confectionary composition of the present invention are conventionally
made by grinding the ingredients once mixed and then compressing or molding the ingredients
to form a suitable means for the delivery of the enzyme. In order to produce tablets
it is necessary to have a free flowing material which has good self binding properties
and which will not stick to the molding or compression equipment.
[0051] An illustrative procedure for formulating the chewing gum composition is as follows:
the gum base is first melted in a heated kettle at 55°-65°C. One or more of the sweeteners
are then added to the gum base followed by one or more flavors, plasticizer. All ingredients
are then mixed for a sufficient period of time to ensure adequate dispersion. The
mixture is then hallowed to cool and the enzyme is added and is cut into suitable
serving sizes.
[0052] In order to enhance shelf stability, in addition to the admixture used in the preparation
of the chewable product being substantially free of water, the finished product should
be packaged in a manner so as to minimize exposure to air and moisture.
[0053] The following Examples are illustrative of the present invention, but it is understood
that the invention is not limited thereto.
Example I
[0054] Enzyme (papain) containing tablet and gum compositions were prepared using conventional
base ingredients as set forth in Tables I and II below.
| TABLE I |
| CHEWABLE TABLET |
| Ingredient |
Wt. % |
| Papain |
0.5 |
| Lycasin 75% |
48.9 |
| Isomalt |
23.1 |
| Hydrogenated vegetable oil |
8.7 |
| Water |
4.8 |
| Gelatin (40% solution) |
2.9 |
| Starch coated dicalcium phosphate |
8.7 |
| Mono-diglyceride mixture |
0.8 |
| Lecithin |
0.3 |
| Aspartame |
0.05 |
| Aspartame K |
0.05 |
| Vanillin |
0.05 |
| Glycerin |
0.1 |
| Sodium bicarbonate |
0.10 |
| Mint flavor |
0.19 |
[0055] The chewable tablet of Table I was prepared by boiling the Isomalt, Lycasin, water,
fat, mono and diglyceride mixture, glycerin, and lecithin to 267-268°F (131°C) after
which glycerin was added and the mixture and cooled to 140°F (60°C). Thereafter sodium
bicarbonate, papain, dicalcium phosphate and the remaining ingredients were added.
Thereafter the mixture cooled to room temperature 72-77°F (23°C) was ground into powder
and compressed into a tablet using a tablet press.
| TABLE II |
| CHEWING GUM |
| Ingredient |
Wt. % |
| Gum base |
31.20 |
| Sorbitol |
28.08 |
| Mannitol |
5.23 |
| Papain |
1.00 |
| Acesulfame K |
0.16 |
| Aspartame |
0.16 |
| Menthol powder |
1.00 |
| Liquid flavor |
0.47 |
| Isomalt PF |
11.70 |
| Isomalt DC |
16.00 |
| Anticaking agents* |
4.00 |
| Flavor |
2.00 |
| * Magnesium stearate, talc, silica gel. |
Papain Enzyme Activity
[0056] Papain activity was measured and monitored in the papain containing chewable tablets
and chewing gums using the Protease Detection kit from Panvera Corp. The activity
kit quantifies protease activity using a fluorenscein thiocarbamoyl (FTC)-casein substrate.
FTC-casein is attacked by the protease, breaking down casein into TC-peptides. The
amount of protease activity is determined by measuring the fluorescence expressed
as relative fluorescence units (RFU). The fluorescence signal generated is proportioned
to the level of activity of papain in the tablet or gum delivery system. For the purposes
of comparison, chewable tablets designated "Tablet A" and chewing gum designated "Chewing
Gum B" were prepared in which papain was not included in these compositions. The papain
activities of the chewable tablet or Table I and the chewing gum of Table II are recorded
in Tables III and IV below as are the papain activities of comparative tablet and
gum compositions.
| TABLE III |
| Protease Activity |
| Chewable Tablet Fluorescence |
| Composition |
4 Weeks (RFU) |
8 Weeks (RFU) |
| Table I |
29,000 |
30,000 |
| A |
2,000 |
2,000 |
| TABLE IV |
| Chewing Gum Fluorescence |
| Composition |
4 Weeks (RFU) |
| Table II |
38,000 |
| B |
1,500 |
[0057] The results recorded in Tables III and IV indicate that the enzyme activity in papain
when incorporated in a chewable tablet or gum is retained over at least a 4 week period.
In Vivo Plaque Reduction Efficacy
[0058] The chewable tablet of Table I was tested for plaque reduction at 2-and 5- hours
after chewing by human volunteers using plaque grown in vivo in an intra-oral retainer
on hydroxyapatite disks. Confocal microscopy was used to visualize and quantify the
changes in plaque coverage and plaque ultrastructure. Plaque removal was also measured
by conventional light microscopy by staining the plaque before and after treatment
with crystal violet indicator and measuring the changes in color intensity. Image
Pro Analysis Software was used to perform the image analysis and the quantitative
measurements. The color intensity was measured and used to determine stain removal.
The greater the intensity, the greater the cleaning efficacy. These results are shown
in Table V below.
| TABLE V |
| Chewable Tablet Plaque Reduction Efficacy |
| |
Total Area (Microns^2) |
% Reduction from Baseline |
Average Cluster Area (Microns^2) |
% Reduction |
| Baseline |
8681 |
--- |
54.45 |
--- |
| 2 hours |
3537 |
59 |
20.10 |
63 |
| 5 hours |
2959 |
66 |
26.18 |
52 |
[0059] Confocal images were made of the plaque before treatment (baseline) and 2 and 5 hours
after treating with the tablet. Qualitatively, images showed that there is less bacterial
coverage 2 and 5 hours after treatment in comparison to baseline. Image analysis was
used to quantify these observations. The results recorded in Table V indicated that
the total plaque area, measured by pixel counting, was significantly reduced in comparison
to baseline and 2 and 5 hours after treatment. Table V also shows that the average
cluster area of the plaque bacteria was significantly reduced after treatment demonstrating
the significant efficacy in reducing plaque without the aid of mechanical assistance.
[0060] In a second study, the plaque before and after staining with crystal violet was viewed
by conventional light microscopy. Image analysis was used to determine the white intensity
measured in pixels, the higher the pixel number, the whiter the stain. The results
from this study are shown in Table VI. The disks stained at baseline were more intensely
colored (blue) than the disks stained 2 hours after treatment with the papain containing
chewable tablet. The disks were 47.3% whiter than baseline, indicating less staining
and therefore, less plaque. Similar results were observed with the papain chewing
gum of Table II as shown in Table VII below.
| TABLE VI |
| Chewable Tablet Staining Removal |
| (White Intensity) |
| |
* |
* |
* |
Average |
Improvement from Baseline |
| Baseline |
125 |
100 |
--- |
112.5 |
--- |
| Treatment |
240 |
200 |
200 |
213.3 |
47.3% |
| *Inventors: What are these units. |
| TABLE VII |
| |
| Chewing Gum Plaque Reduction Efficacy |
| |
| |
Total Area (Microns^2) |
% Reduction from Baseline |
Average Cluster Area (Microns^2) |
% Reduction |
| Baseline |
47,832 |
--- |
2897 |
--- |
| 2 hours |
38,137 |
16 |
2446 |
15 |
| 5 hours |
27,267 |
52 |
1398 |
52 |
1. Kaubare Konfektzusammensetzung, die Zahnoberflächen eine Einheitsdosis von Plaque
reduzierendem Enzym zuführt, wobei die Zusammensetzung (A) 0,1 bis 3 Gew.-% Enzym,
das bewirkt, dass Plaquebildung und -haftung an Zahnoberflächen unterbrochen oder
gestört wird, wobei das Enzym eine Protease ist, (B) festes Basismaterial umfasst,
und (C) die Zusammensetzung ferner (D) enzymstabilisierendes Mittel, das ein Mittel
ist, welches das Enzym durch Chelatisieren von Metallverunreinigungen vor Inaktivierung
schützt, oder 0,05 bis 1,5 Gew.-% reduzierendes Mittel, welches das Enzym gegen Oxidation
stabilisiert, (E) weniger als 5 Gew.-% Wasser umfasst, wobei die Protease aus einem
natürlichen Fruchtprodukt extrahiert worden ist und in das feste Basismaterial der
Zusammensetzung bei einer Temperatur von weniger als 80°C eingeschlossen worden ist.
2. Kaubare Konfektzusammensetzung nach Anspruch 1, wobei das Enzym Papain ist.
3. Kaubare Konfektzusammensetzung nach Anspruch 1, wobei die Zusammensetzung in Form
einer Tablette ist.
4. Kaubare Konfektzusammensetzung nach Anspruch 1, wobei die Zusammensetzung ein Kaugummi
ist.
5. Kaubare Konfektzusammensetzung nach Anspruch 1, die ferner einen nicht-kariogenen
Süßstoff umfasst, der ein Zuckeralkohol ist.
6. Kaubare Konfektzusammensetzung nach Anspruch 1, die ferner einen nicht-kariogenen
Süßstoff umfasst, der ein künstlicher Süßstoff ist.
7. Kaubare Konfektzusammensetzung nach Anspruch 1, die ferner einen nicht-kariogenen
Süßstoff umfasst, der ein Zuckeralkohol eines Disaccharids ist.
8. Kaubare Konfektzusammensetzung nach Anspruch 1, die ferner einen nicht-kariogenen
Süßstoff umfasst, der in der Zusammensetzung in einer Konzentration von 25 bis 95
Gew.-% vorhanden ist.
9. Kaubare Konfektzusammensetzung nach Anspruch 1, wobei das enzymstabilisierende Mittel,
welches das Enzym durch Chelatisieren von Metallverunreinigungen vor Inaktivierung
schützt, 0,01 bis 1 Gew.-% eines Mittels ausgewählt aus EDTA und Natriumglukonat ist.
10. Kaubare Konfektzusammensetzung nach Anspruch 1, wobei das Mittel, welches das Enzym
stabilisiert, aus reduzierenden Mitteln ausgewählt ist.
11. Kaubare Konfektzusammensetzung nach Anspruch 1, wobei die Zusammensetzung ferner ein
Enzym ausgewählt aus Carbohydrasen umfasst.
1. Composition de confiserie à mâcher destinée à apporter à la surface des dents une
dose unitaire d'enzyme antiplaque, la composition comprenant (A) de 0,1 à 3 % en poids
d'une enzyme qui a pour fonction d'interrompre ou d'interférer avec la formation et
l'adhésion à la surface des dents de la plaque dentaire, laquelle enzyme est une protéase,
(B) un matériau de base solide, et (C) la composition comprenant en outre (D) un agent
de stabilisation de l'enzyme qui est un agent qui, en chélatant les impuretés métalliques,
protège l'enzyme de l'inactivation ou de 0,05 à 1,5 % en poids d'un agent réducteur
stabilisant l'enzyme contre l'oxydation ; (E) moins de 5 % en poids d'eau, dans laquelle
la protéase est extraite d'un produit naturel à base de fruits et est incorporée dans
le matériau de base solide de la composition à une température inférieure à 80 °C.
2. Composition de confiserie à mâcher selon la revendication 1, dans laquelle l'enzyme
est de la papaïne.
3. Composition de confiserie à mâcher selon la revendication 1, dans laquelle la composition
se présente sous la forme d'un comprimé.
4. Composition de confiserie à mâcher selon la revendication 1, dans laquelle la composition
est un chewing-gum.
5. Composition de confiserie à mâcher selon la revendication 1, comprenant en outre un
édulcorant non-cariogène qui est un polyol.
6. Composition de confiserie à mâcher selon la revendication 1, comprenant en outre un
édulcorant non-cariogène qui est un édulcorant artifciel.
7. Composition de confiserie à mâcher selon la revendication 1, comprenant en outre un
édulcorant non-cariogène qui est un polyol de type disaccharide.
8. Composition de confiserie à mâcher selon la revendication 1, comprenant en outre un
édulcorant non-cariogène qui est présent dans la composition à une concentration de
25 à 95 % en poids.
9. Composition de confiserie à mâcher selon la revendication 1, dans laquelle l'agent
de stabilisation de l'enzyme qui, en chélatant les impuretés métalliques, protège
l'enzyme de l'inactivation, représente de 0,01 à 1 % en poids d'un agent choisi parmi
l'EDTA et le gluconate de sodium.
10. Composition de confiserie à mâcher selon la revendication 1, dans laquelle l'agent
stabilisant l'enzyme est choisi parmi les agents réducteurs.
11. Composition de confiserie à mâcher selon la revendication 1, dans laquelle la composition
comprend en outre une enzyme choisie par les carbohydrases.